Introduction
Despite the paucity of knowledge regarding the molecular oncogenesis of most human brain tumors, our understanding of the molecular pathways causing medulloblastoma (MB), the most common malignant brain tumor in children, has advanced considerably. We now know that MB can occur in the setting of two major inherited genetic syndromes. In these two hereditary diseases, Turcot and Gorlin syndrome, the Wnt and Hedgehog (Hh) signaling pathways respectively, are dysregulated and may lead to MB as well as other developmental malformations and cancers Wechsler-Reya and Scott, 2001; Yokota et al., 2002) . MB is also found in approximately 20% of offspring from heterozygous transgenic mice carrying a targeted deletion of the Ptch gene that results in constitutive Hh signaling (Goodrich et al., 1997; Wetmore et al., 2001) . Both Wnt and Hh signaling pathways play crucial roles in the proliferation and differentiation of cerebellar granule cells, from which MBs are thought to arise (Yokota et al., 1996; Buhren et al., 2000) .
Primitive neuroectodermal tumors (PNETs), such as MB, are characterized by dysregulation of cellular proliferation, apoptosis, or differentiation signals that normally occur at critical developmental stages in neurogenesis (Wechsler-Reya and Scott, 2001) . By histology, MB is composed mainly of undifferentiated small, round blue cells. However, many MBs exhibit markers of neuronal differentiation including expression of neuronal transcriptional factors from the PAX (Kozmik et al., 1995; Vincent et al., 1996) , ZIC (Yokota et al., 1996; Michiels et al., 1999; Pomeroy et al., 2002) , and NEUROD gene families (Rostomily et al., 1997) . These neuronal transcriptional factors are developmentally regulated and govern the expression of several genes that influence cell fate in the cerebellar granule cell lineage, and presumably affect the growth and differentiation of MB. In this study, we sought to identify genes that are differentially expressed in a sporadic human classical MB as compared with normal human cerebellar tissue; and in a murine Ptch þ /À MB as compared with non-neoplastic cerebellar tissue from an unaffected littermate. We utilized the technique of suppressive subtractive hybridization (SSH), a polymerase chain reaction (PCR)-based method of subtractive cloning, to identify genes overexpressed in the two different types of MB (Diatchenko et al., 1996) . Although a number of genes were isolated using this strategy, we concentrated our efforts on those genes that are known to be developmentally regulated in the central nervous system (CNS). Confirmation of the results obtained from the SSH screen was performed by reverse transcription (RT)-PCR and Western blot analysis of non-neoplastic cerebellum, MB specimens and various cell lines. Our results show that many MBs share certain expression patterns of these developmentally regulated genes.
Results

Isolation of upregulated clones by screening subtracted cDNA libraries
Over 300 clones were screened in each library, from which 57 differentially regulated clones were selected. Their plasmids were then purified and cDNAs sequenced. The percentage of upregulated clones was therefore approximately 20%. Of the 32 clones identified from the human MB library, 12 were multiple hits and we selected six for further evaluation (Table 1) . Among the fragments isolated from the human MB cDNA library, most were found to bear homology to known sequences in the human genome database. Other cDNA fragments could be assigned a genomic location and a hypothetical protein structure. However, the structure and function of some human ESTs found through homology searches are still largely unknown. Among the 25 fragments isolated from the murine cDNA subtractive library, 17 identified genes were repeat hits with Ccnd2 being represented 12 times (almost 50% of all clones). This may be due to a high native number of mRNA species, or related to the preamplification step used for generating the murine library. We selected five of the nine different genes identified in the murine cDNA library for verification.
In both libraries, we identified many developmentally regulated genes involved in cellular proliferation, antiapoptosis, and differentiation of the cerebellar granule cells (Table 2a, b) . Housekeeping, ribosomal and mitochondrial genes were rarely isolated, indicating that the subtractive hybridizations were effective.
A total of 11 clones of differentially expressed and developmentally regulated genes were selected from both MB libraries and subjected to further analysis by RT-PCR (Figure 1 ). The genes from the human MB library encode for the nuclear matrix protein NRP/B (ENC1), the homeobox protein OTX2, SRY (sex determination region Y)-box 4 protein SOX4, Neuronatin (NNAT), human homologue of Drosophila BARHL1, and Unc-33-like protein (ULIP). The genes selected from the murine cDNA library are cyclin D2 (CCND2), thymopoietin (TMPO), Musashi-1 (MSH1), protein phosphatase 2A inhibitor-2 (I-2PP2A), which is a murine homolog of the human SET gene, and the candidate netrin receptor UNC5H4. 
RT-PCR analysis of MB cell lines and specimens
To be considered upregulated in MBs, the tested genes had to show a threefold greater expression in tumor samples than in normal cerebellum by semiquantitative RT-PCR. In most MB samples examined, such overexpression was found (Figure 1 ). Moreover, there RT-PCR analysis of the human MB tumor samples revealed three different expression patterns for the 11 genes examined: (1) genes that were largely coexpressed in a similar pattern (upregulated or not expressed) across all the tumor samples examined referable to nonneoplastic cerebellum (BARHL1, NNAT, SOX4, UNC4H5, CCND2); (2) genes that were overexpressed throughout all the tumor samples ULIP, ENC1, SET, TMPO, MSH1; and (3) a gene that had no specific pattern of expression in the tumor samples (OTX2) (Figure 1 ). The lack of expression of all of these genes in the non-neoplastic cerebellum is further evidence of the efficacy of the SSH technique. The uniform expression of the b-actin control gene indicates good integrity and equal template loading of the RNA from the tumor specimens.
The expression profile of the 11 genes in the array of human tumor cell lines were also categorized into three groups: (1) genes that were not primarily expressed by any of the cell lines (BARHL1, OTX2, NNAT, and UNC5H; (2) genes that were overexpressed by all the cell lines (TMPO, SET, and SOX4), and (3) genes that showed variable expression across the cell lines without any distinct pattern (ULIP, ENC1, MSH1 CCND2) ( Figure 2 ). Interestingly, in the first category, BARHL1, NNAT, and UNC5H, although not expressed in the tumor cell lines, were expressed in the MB tumor samples suggesting that these genes may be specific to the MB tumor specimens. In the second group, TMPO and SET were also expressed throughout the panel of MB tumors and could represent genes that are important in a proliferative state regardless of tumor phenotype.
Analysis of notch and WNT pathways in MB specimens and cell lines CCND2 and MSH1 were analysed by Western blot as they were found to have elevated transcripts by RT-PCR ( Figure 3 ). CCND2 expression was elevated in the PFSK and TE671 cell lines and in three of the six MB specimens, relative to non-neoplastic cerebellum. While it is known that CCND2 is upregulated via the HH pathway in various MB tumors and cell lines, we also wanted to analyse the expression of CCND1, a WNTregulated cyclin D, in the same samples. CCND1 was moderately expressed in all but one MB specimens and in six of eight MB cell lines. As CCND1 is known to be a direct target of CTNNB1 (b-catenin), we were not surprised by their correlative expression in the MB cell lines. Interestingly, there was little correlation in expression of CCND1 and b-catenin in the MB tumor samples.
MSH1 protein was not found in cerebellum, but was observed strongly in TE671 and D341 and to a lesser degree in the DAOY MB cell line; high MSH1 protein levels were observed in four of six human MB tumor specimens. As NUMB is negatively regulated by MSH1 expression, we studied NUMB expression in the same samples. NUMB was variably expressed as two isoforms throughout the MB cell lines and tumor specimen. Interestingly, there was no inverse correlation between MSH1 and NUMB expression as might be expected in the MB tumor samples. Figure 2 RT-PCR of genes interest in various human cancer cell lines. Similar to the MB specimens, the expression profile in the array of cell lines could be categorized into three groups: (1) genes that were not primarily expressed by any of the cell lines (BARHL1, OTX2, NNAT, and UNC5H; (2) genes that were overexpressed by all the cell lines (TMPO, SET, and SOX4), and (3) genes that showed variable expression across the cell lines without any distinct pattern (ULIP, ENC1, MSH1 CCND2) b-Actin demonstates equal expression across the panel. hCB, non-neoplastic human cerebellum; HMB, human medulloblastoma case, from which human MB subtractive library was developed, as negative and positive control Developmentally regulated genes in medulloblastoma N Yokota et al Hes1 luciferase reporter assays HES1-luciferase activity in TE671 cells was higher by 3--fold compared to the non-MSH1-expressing cell lines (Figure 4a ). To verify MSH1 regulation of the HES1-luciferase reporter, we transfected MSH1 into two non-MSH1-expressing MB cell lines, UW228 and UW426. MSH1 expression in these cell lines resulted in a 6-8-fold increase in HES1 promoter activity (Figure 4b ). Transfection of these cell lines with the intracellular domain of NOTCH1, a strong activator of HES1, resulted in a 40-50-fold induction of HES1 activity as compared to the wild-type cell lines. These data suggest that the Notch pathway may be functional in the UW228 and UW426 MB cell lines.
Discussion
Identification of genes that are differentially expressed between cancer cells and nonmalignant cells of the same phenotype may lead to a greater understanding of which oncogenic processes and signaling pathways are pertinent in cellular transformation leading to MB. Human MB, as with many human cancers, is characterized by genetic and phenotypic heterogeneity despite a fairly uniform appearance by light microscopy. As different genomic, transcriptomic, and proteomic profiles may give rise to a specific tumor type, it is becoming increasingly important to map these profiles since each may be associated with responses to different treatment regimens. As such, our study was designed to identify genes with differential expression between MBs and cells of the non-neoplastic cerebellum. To achieve our goal, we used two different models: in the first, we compared overexpressed genes in a sporadic, classical human MB to human non-neoplastic cerebellum; and in the second, we took advantage of the HH-driven, murine MB model that arises in Ptch þ /À heterozygous knockout mice, and compared a MB from these mice to the normal cerebellum of a Ptch þ /À littermate. Interestingly, but perhaps not unexpectedly, we show that the differentially expressed and developmentally regulated genes from each model, the human sporadic MB and the murine Ptch þ /À MB, are different. Several new techniques have recently been developed for analysing altered gene expression. These include mRNA differential display (Liang and Pardee, 1992) , serial analyses of gene expression (SAGE) (Velculescu et al., 1997) , cDNA microarray (Chee et al., 1996; Chu et al., 1998) , and SSH (Diatchenko et al., 1996) . Whereas mRNA differential display is the most complicated and labor-intensive, both SAGE and cDNA array are limited for identifying unknown genes because they a priori require known genetic information. SSH is an efficient and versatile PCR-based method of identifying rare, tumor-specific transcripts (Ji et al., 2002) . We previously used SSH to identify differentially expressed genes in an in vivo animal model of cerebral ischemia (Yokota et al., 2001) . This is the first report of using SSH on human and murine MB to identify differentially expressed genes -many of which have not previously been linked to MB oncogenesis. As with other PCR-based subtraction methods, some genes were identified by multiple cDNAs (seen as multiple hits in the database search). This could be due to a more abundant transcript resulting in higher cDNA representation, or a large transcript leading to multiple isolated cDNA fragments, or an artefact of PCR amplification. The number of unknown ESTs in the human genome project database has dramatically decreased, but the number in the murine database is still quite large and therefore it is not surprising that our identification rate was higher for human ESTs than those obtained from the murine library. After differentially expressed MB genes were identified, a subset was chosen for further analysis. We chose genes that are developmentally regulated, important for cerebellar development or are expressed in the cerebellar granule cell precursors, the cells that may give rise to MB. Some of these genes direct important cellular processes such as cell cycle control, apoptosis, and phosphorylation, Several are members of well-studied developmental gene families such as the homeobox and Sry-box gene families, or are components of important developmental pathways such as the Wnt and Notch signaling pathways.
We identified nine differentially expressed genes from the murine Ptch þ /À MB and analysed five in more detail. As the murine cDNA library was generated from a ptch þ /À MB in which HH signaling is activated, the finding of CCND2 upregulation supports the efficacy of the technique used. We identified 21 differentially expressed genes from the classical human MB and further characterized six genes: ULIP, SOX4, NNAT, ENC1, OTX2, and BARHL1.
Increased expression of the cell cycle control gene, CCND2, was detected in our murine Ptch þ /À MB library. Cyclin D, a G1/S cyclin, promotes cells to enter S phase by releasing E2F transcription factors from the retinoblastoma protein (Rb) (Weinberg, 1995) . CCND2 is transiently expressed in the external granule cells during cerebellar ontogenesis (Ross et al., 1996) . In mice lacking CCND2, there is a paucity of cerebellar granule cells from a decreased proliferative potential and an increased apoptotic rate (Huard et al., 1999) . Recently, CCND2 was shown by microarray analysis to be a target gene of the zinc-finger transcriptional factor, GLI1, and therefore under the regulation of the HH pathway (Yoon et al., 2002) . HH signaling promotes transcription of CCND2 and cell growth (Duman-Scheel et al., 2002) . In our study, the upregulation of Ccnd2 in the Ptch þ /À MB library, and its high expression in many MB cases support a role for CCND2 in MB oncogenesis.
We also looked at CCND1 and CCND2 expression by Western blot analysis. Interestingly, while there was some overlap in expression of CCND1 and CCND2 in the MBs tested here, CCND1 was more widely expressed in the MB samples than was CCND2. Not surprisingly, there was good correlation between the expression of CNNTB1 and CCND1 in the MB cell lines, suggesting a potential role of the WNT pathway in these cell lines.
Our isolation of Unc5h4 in murine MB suggests a possible role of disrupted apoptosis in this tumor. UNC5H is a membrane netrin-1 receptor crucial for axon guidance, neuronal migration, growth cone attraction, and/or repulsion (Hong et al., 1999) . Typically, UNC5H acts as dependence receptor inducing apoptosis when unbound to ligand and may be a tumor suppressor gene in such tissues as colon, breast, ovary, and uterus. However, when bound to netrin-1, UNC5H acts as a potent survival factor (Llambi et al., 2001) . UNC5H2 is highly expressed in cerebellar external granule cells along the parallel fibers interacting with Purkinje cell dendrites (Leonardo et al., 1997) . Various UNC5H homologs are known (Leonardo et al., 1997) and human UNC5H4 (UNC5D) was recently found in the human genome database. Another neuronal process-associated protein identified in our human MB library is the Unc-33-like phosphoprotein (ULIP) (Goshima et al., 1995) , a developmentally expressed homolog (Byk et al., 1996) of Caenorhabditus elegans Unc-33 (Li et al., 1992) , which is highly expressed between E15 and P15 in rat cerebellum (Wang and Strittmatter, 1996) .
An interesting finding in this study was the overexpression of Msh1 in the murine MB. MSH1 is an evolutionarily conserved gene encoding a neural RNAbinding protein. In mammals, MSH1 is selectively expressed in neural progenitor cells (Okano et al., 2002) and is involved in cellular differentiation and tumorigenesis. In stem cells, MSH1 maintains the cells in an undifferentiated state through post-transcriptional inhibition of NUMB expression ), which in turn acts as an intracellular Notch antagonist and is involved in regulation of neuronal differentiation (Wakamatsu et al., 1999) . Accordingly, MSH1 is considered a positive regulator of Notch signaling. Interestingly, it has been shown that MSH1 is expressed in certain types of brain tumors such as glioblastoma and MB, and its expression level correlates with the malignancy and proliferative activity of gliomas (Kanemura et al., 2001) . Activation of Notch signaling results in tumorigenesis by virtue of inhibition of apoptosis and maintenance of an immature cell phenotype (ArtavanisTsakonas et al., 1999) . In keeping with MB formation, Notch2 activity has been shown to halt the differentiation of cerebellar granule cells and to act as a strong mitogen (Solecki et al., 2001 ). As such, high levels of MSH1 expression may lead to increased cellular proliferation. Our results indicate a potential dysregulation of the Notch pathway as MSH1 and NUMB expression levels were not inversely related in the same tumor samples. In support of this statement, the only cell line to have high MSH1 expression, TE671, also Developmentally regulated genes in medulloblastoma N Yokota et al demonstrated high levels of downstream Notch activity as measured by the HES1-luciferase reporter construct. Furthermore, induced expression of MSH1 in non-MSH1-expressing cell lines leads to a 6-8-fold induction of HES1 activity. This induction suggests that the intracellular Notch signaling pathway is intact in these MB cell lines.
The SOX (Sry-box) genes are developmentally regulated and homologous to the HMG-box region of the testis-determining gene, SRY (Laudet et al., 1993) . SOX4 is expressed in mouse T-and pre-B-lymphocytic cell lines along with LEF-1, and controls lymphocyte differentiation (van de Wetering et al., 1993) . In the developing cerebellum, SOX4 is expressed in the external granule cells (Cheung et al., 2000) . Interestingly, Sox4 expression was repressed in stable Gli1-transfected rat kidney epithelial cells (Yoon et al., 2002) . A downstream effector of Wnt signaling along with LEF-1, SOX4 may play a role in tumor cell differentiation. SOX4 is known to be overexpressed in MB, especially the classic variant and has been suggested as a favorable prognostic factor (Lee et al., 2002) .
Other identified genes from the MB libraries are important in cerebellar development. The homeobox proteins (BARH1, OTX2) and NNAT exhibit neuralspecific expression throughout early development. Mammalian BARHL1 is expressed in the rhombencephalon, including the cerebellar external granule cells and spinal dorsal sensory interneurons, and required for the generation of specific neuronal subtypes (Bulfone et al., 2000) . BARHL1 is a candidate gene for Joubert syndrome, a rare developmental disorder characterized by aplasia/hypoplasia of the cerebellar vermis, possibly playing an important role in cerebellar ontogenesis. Mouse BARHL1 activates the proneural gene neurogenin2 (ngn2) and inhibits MASH1 (Saito et al., 1998) . Human BARHL1 has been mapped to chromosome 9q34 (Bulfone et al., 2000) , adjacent to PTCH (9q22.3), SET (9q34.11), and NOTCH1 (9q34.3) -an important locus known to be deleted in MBs (Bayani et al., 2000) . Another identified homeobox protein, mammalian Otx2, is expressed in the telencephalon, diencephalon, and mesencephalon of developing mouse brain embryos. (Boncinelli et al., 1993) . In the cerebellum, Otx2 is expressed in the entire cerebellar granule cell lineage (Frantz et al., 1994) . Recently, OTX2 and ZIC1 were identified as differentially expressed genes in MB by SAGE (Michiels et al., 1999) . Otx2 À/À mice are embryonic lethal showing defective development of the rostral neuroectoderm resulting in a headless phenotype (Simeone et al., 1992) .
In summary, several different patterns of gene expression were found in our survey of MB tumor samples. The heterogeneity of MB tumors was revealed by testing with multiple markers important for cerebellar development that were derived from our SSH screen. This suggests that MB is not a uniform tumor, but may be comprised of several possible molecular entities as illustrated by the patterns of gene expression found in the MB samples and cell lines examined here. Several reports implicate the WNT and HH pathways in the desmoplastic MB subtype (Rubin and Rowitch, 2002) . Furthermore, our results suggest the potential dysregulation of the Notch pathway in MB. The identification of additional MB-associated markers may not only improve MB tumor grading but may also predict for patients who will respond best to a given therapy. In future studies, we will examine the panel of genes identified here and their pattern of expression against large numbers of patient samples linked to clinical outcome and survival data.
Materials and methods
Cell lines and culture conditions
MB cell lines TE671, ONS76, UW228, UW426, PFSK, DAOY, and D283 were gifts of Dan Fults, the University of Utah, Salt Lake city, and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) fetal bovine serum (FBS, Wisent, St Bruno, Quebec, Canada), 200 mM L-glutamine, 5 U of penicillin/ml, and 5 mg of streptomycin sulfate/ml. D341 cells were grown in DMEM supplemented with 20% FBS. The other cell lines used in this study were astrocytoma cell lines (SF188, U87, SF539, U251, SF126, U343, and U373), and other human cancer cell lines (Jurkat, T-cell lymphoma; Ramos, Burkitt's lymphoma; HeLa, squamous cell carcinoma; SA052, osteosarcoma; U205, osteosarcoma; COLO320DM, adenocarcinoma; NCI-173, small-cell carcinoma; and NCI-H596, adeno-squamous carcinoma). These cell lines have all been well characterized and were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA).
Origin of MB cDNA libraries
A human MB subtractive cDNA library was developed from a tumor specimen of a 5-year-old female subject diagnosed with MB at The Hospital for Sick Children, Toronto. Histopathological examination showed a classical MB containing small round tumor cells with abundant chromatin and scanty, poorly defined cytoplasm. Control mRNA was derived from non-neoplastic human cerebellum and purchased from Clontech (Pale Alto, CA, USA).
A murine MB subtractive cDNA library was derived from specimens of Ptch þ /À heterozygous mice. Control mRNA for this subtraction was generated from normal cerebellum of unaffected littermates. Ptch þ /À heterozygous mice were a gift from CC Hui, The Hospital for Sick Children. Mice genotyping was performed by PCR on DNA isolated from tail specimens as described previously (Goodrich et al., 1997) .
Permission to use the above biological materials was granted by the Research Ethics Board and the Committee of the Animal Care Facility of The Hospital for Sick Children.
PCR-based suppression subtractive hybridization
Total RNA was prepared with TRIZOL (Invitrogen Canada Inc., Burlington, Canada). mRNA was then isolated with Oligotex (QIAGEN Inc., Mississauga, Canada). Doublestranded cDNA (ds cDNA) was synthesized by the GublerHoffman method using a PCR-Select cDNA Subtraction Kit (Clontech, Palo Alto, CA, USA). For the murine Ptch þ /À library, the amount of mRNA retrieved was limited such that cDNA amplification was performed using a SMART PCR cDNA Synthesis Kit (Clontech, Palo Alto, CA, USA).
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Subtractive cDNA libraries for the human and murine materials were established by SSH as previously described (Diatchenko et al., 1996; Yokota et al., 2001) . Briefly, ds cDNA was digested with the blunt-ended restriction enzyme RsaI. Tester ds cDNA was synthesized from the MB tumor tissue, and driver ds cDNA from normal cerebellum. Following heat denaturation (1.5 min at 981C), the digested tester ds cDNA was ligated to either adapter 1: (5 0 -CTAATACGACT-CACACTATAGGGCTCGAGCGGCCGCCGGGCAGGTA-CCTGCCCGG-3 0 ) or adapter 2R: (5-CTAATACGACTCA-CACTATAGGGCAGCGTGGTCGCGGCCGAGGTACC-TCGGCCG-3 0 ), in separate reactions. They were then mixed with an excess of driver cDNA and hybridized (50 mM HEPES, pH 8.3, 0.5 M NaCl, 0.2 mM EDTA) for 10 h at 681C. After the first hybridization, these two samples were mixed, and the heat-denatured driver cDNA was added to the same hybridization buffer. The hybridization was allowed to proceed for an additional 10 h at 681C. The final hybridization mixture was diluted in dilution buffer (20 mM HEPES, pH 8.3, 50 mM NaCl, 0.2 mM EDTA), heated at 721C for 7 min and stored at À201C. PCR amplification was performed using the Advantage cDNA PCR Core Kit (Clontech, Palo Alto, CA, USA). The subtracted cDNA was diluted and the first PCR was performed using the PCR primers P1 (5 0 -CTAATAC-GACTCACACTATAGGGC-3 0 ) using the following protocol: 751C for 7 min, followed by 30 cycles at 941C for 30 s, 681C for 30 s, and 721C for 150 s, and final extension at 681C for 7 min. The amplified product was diluted and secondary PCR was performed under the same conditions for 10 cycles using the nested primers PN1 (5 0 -TCGAGCGGCCGCCGGGCAGGT-3 0 ) and PN2R (5 0 -AGCGTGGTCGCGGCCGAGG-T-3 0 ). Products from the secondary PCR were inserted into pBluescript II (Stratagene, La Jolla, CA, USA) at the EcoRV site and transformed into competent cells, Escherichia coli DH5a. (Invitrogen, Burlington, Canada).
Isolation of upregulated cDNA fragments and their identification
Randomly selected bacterial colonies were selected and amplified under the same conditions for 20 cycles with the nested primers 1 and 2R described above. The PCR products were blotted onto GeneScreen Plus (MEN Life Science Products Inc., Boston, MA, USA), denatured twice in 0.5 N NaOH on Whatman 3 MM filter paper for 2 min, then neutralized by dipping in Tris-HCl (pH 7.5) for 2 min and finally were fixed to the filter by ultraviolet light irradiation. The forward-and reverse-subtracted secondary PCR products were purified using QIAquick Spin (QIAGEN Inc., Mississauga, Canada) and labeled with 32 P ATP (Amersham Pharmacia Biotech, Piscataway, NJ, USA) using a Random Primed DNA Labeling Kit (Roche, Laval, Quebec, Canada). The filters were air-dried and prehybridized in ExpressHyb Hybridization Solution (Amersham Pharmacia Biotech, Piscataway, NJ, USA) with herring sperm DNA, oligonucleotides of nested primers, and their complementary sequences for 1 h. Hybridization was allowed to proceed at 681C overnight after the addition of 10 6 c.p.m./ml of 32 P-labeled cDNA probes prepared from either the MB, or the non-neoplastic cerebellum. The filters were washed twice with 2 Â SSC and 0.1 Â SSC with 0.5% SDS at 651C and exposed to an imaging plate and analysed by STORM gel and blot imaging system (Amersham Bioscience, Sunnyvale CA, USA).
The clones that were positive for the subtracted probe and negative for the reverse-subtracted one were selected and their plasmids were prepared once again. The method for plasmid DNA preparation has been described previously (Sambrook et al., 1989 ). The desired cDNAs were then purified using QIAEX II (QIAGEN Inc., Mississauga, Canada), and sequenced by the dideoxy chain termination method using a DNA autosequencer, 373A/GeneScanTM (PE Biosystem, Foster City, CA, USA). DNA sequences were analysed by the DNASIS program (Hitachi, Japan), and a homology search was performed against the sequences in the database using the NCBI BLAST program (http://www.ncbi.nih. gov:80/BLAST/).
RT-PCR in MB specimens and cell lines
RT-PCR analyses were performed for developmentally regulated genes from the SSH experiments in 25 cases of sporadic MB and 19 human cancer cell lines (4 MB cell lines (Uw228, DAOY, PFSK, Med344); seven glioma cell lines (SF188, U87, SF539, U251, SF126, U343, U373); and other human cancer cell lines (Jurkat, Ramos, HeLa, SA052, U205, COLO320DM, NCI-173, and NCI-H596)). mRNA was prepared as described above. A 5 mg measure of the total RNA prepared from normal cerebellum, MBs, and human cancer cell lines were digested with DNaseI, and used as templates for cDNA synthesis with the oligo (dT) (Sambrook et al., 1989; Liang and Pardee, 1992; Velculescu et al., 1997; Yokota et al., 2001; Ji et al., 2002) primers using the Omniscript cDNA synthesis Kit (Qiagen Inc., Mississauga, Canada). The reaction mixture was incubated at 371C for 2 h, and then terminated by heating at 931C for 5 min. The resulting cDNA mixture was diluted in 100 ml of 1/10 TE (pH 8.0) before PCR amplification. PCR amplification was performed by adding a 2-ml aliquot of each cDNA sample to 25 ml of the reaction mix from the Advantage cDNA PCR Core Kit (Clontech, Palo Alto, CA, USA). The gene-specific primers used in this study were designed from the known sequences of the isolated genes shown in Table 1 . The following amplification protocol was used: denaturation at 951C for 30 s, annealing at each temperature (shown in Table 1) for 30 s, and extension at 721C for 1 min. After PCR, 8 ml of each of the PCR products were electrophoretically separated on 2% agarose gel and stained with ethidium bromide. Densitometric analyses were performed including standardization from the control (b-actin) band as previously described (Yokota et al., 2001) . The rate of amplification with the primer sets used here was exponential for each cycle determined, and the pattern of amplification remained constant through different runs.
Western blot analysis of MB specimens and cell lines
MB tumour specimens and cell lines were lysed in PLC lysis buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 10% (vol/vol) glycerol, 1% (vol/vol) Triton X-100, 1.5 mM MgCl 2 , 1 mM EDTA, 10 mM NaPP I , 100 mM NaF) containing complete protease inhibitors (Roche, Laval, Quebec). Lysates were cleared by centrifugation at 14 000 r.p.m. at 41C for 10 min. A measure of 40 mgof total protein lysates were resolved on 10% SDS-PAGE gels and electrophoretically transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Bedford, MA, USA). Membranes were blocked with 5% (wt/vol) skim milk powder in 1 Â Tris-buffered saline with 0.05% Tween 20 for 30 min prior to the antibody addition. Blocked membranes were incubated for 1 h at room temperature with rat antihuman MSH-1 antibody (a kind gift from Professor H Okano, Dokkyo University, Tochigi, Japan) at a dilution of 1 : 1000, rat anti-human cyclin D2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a dilution of 1 : 1000, antihuman actin antibody (Sigma, The Woodlands, TX, USA) at a dilution of 1 : 1000, mouse anti-human cyclin D1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a dilution of 1 : 1000, rabbit anti-numb (UBI, Waltham, MA, USA), and rabbit antib-catenin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a dilution of 1 : 1000. Membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (BioRad, Hercules, CA, USA) at room temperature for 45 min at a dilution of 1 : 5000. Bound antibody was detected using enhanced chemiluminescence reagent (ECL, PerkinElmer, Boston, MA, USA).
Hes1 luciferase reporter assays
A MSH1-expressing cell line (TE671) and cell lines that do not express MSH1 (ONS76, PFSK, UW228, UW426) were assayed for Notch signaling activity. TE671, ONS76, PFSK, UW228, and UW426 cells were seeded on six-well plates and transiently transfected with 1 mg of HES1-luciferase reporter construct (a gift from Jane McGlade, Toronto, Ontario, Canada) using Fugene 6 transfection reagent (Roche, Laval, Quebec, Canada). b-Galactosidase reporter construct (1 mg) was included in each transfection to control for efficiency. Luciferase and b-galactosidase assays were performed 24 h post-transfection as previously described (McGill and McGlade, 2003) . Each transfection was performed in duplicate and each experiment was conducted four times.
UW228 and UW426 cells were seeded on six-well plates and transiently transfected with 1 mg of HES1-luciferase reporter construct, 1 mg of b-galactosidase reporter construct, and either 1 mg of empty vector, 1 mg pEF-MSH1 expression construct, or pcDNA3.1-NICD (NOTCH1 intracellular domain) using FUGENE 6 at a 3 : 1 ratio. Luciferase and bgalactosidase assays were performed 24 h post-transfection. Each transfection was carried out in triplicate and each experiment was conducted three times.
